Cintas (CTAS)
(Delayed Data from NSDQ)
$788.50 USD
+3.86 (0.49%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $788.03 -0.47 (-0.06%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$788.50 USD
+3.86 (0.49%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $788.03 -0.47 (-0.06%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth C Momentum C VGM
Zacks News
Founded in 1968 and headquartered in Cincinnati, OH, Cintas Corporation provides specialized services to businesses of all types throughout North America. It also operates in Europe, Asia and Latin America. The company designs, manufactures, implements corporate identity uniform programs, and provides entrance mats, restroom supplies, promotional products and first aid and safety products for diversified businesses. Notably, the company provides products and services through distribution and retail channels to small service and manufacturing companies as well as leading corporations.
Cintas' (CTAS) Q1 Earnings and Sales Beat, Increase Y/Y
by Zacks Equity Research
Cintas' (CTAS) fiscal Q1 results reflect strength in Uniform Rental and Facility Services, offset by high costs & expenses. Earnings and sales projections for fiscal 2022 imply year-over-year growth.
Cintas (CTAS) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Cintas (CTAS) delivered earnings and revenue surprises of 12.68% and 1.51%, respectively, for the quarter ended August 2021. Do the numbers hold clues to what lies ahead for the stock?
Cintas (CTAS) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Cintas (CTAS) Q1 earnings to reflect healthy business in the hygiene and healthcare markets, gains from buyouts, and solid product offerings. High costs and taxes are likely to have been concerning.
Micron, Cintas, McCormick and JPMorgan are part of Zacks Earnings Preview
by Zacks Equity Research
Micron, Cintas, McCormick and JPMorgan are part of Zacks Earnings Preview
Making Sense of the Q3 Earnings Picture and Beyond
by Sheraz Mian
Recent updates on the revisions trends have been somewhat disconcerting, as you can see in the chart below that tracks the evolution of Q3 earnings growth expectations...
Earnings Preview: Cintas (CTAS) Q1 Earnings Expected to Decline
by Zacks Equity Research
Cintas (CTAS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cintas (CTAS) Tops on Q4 Earnings & Sales, Gives Solid View
by Zacks Equity Research
Cintas' (CTAS) Q4 results reflect gains from strength in Uniform Rental and Facility Services, offset by higher costs and expenses. Earnings and revenue projections for fiscal 2022 suggest year-over-year growth.
Cintas (CTAS) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Cintas (CTAS) delivered earnings and revenue surprises of 6.01% and 0.63%, respectively, for the quarter ended May 2021. Do the numbers hold clues to what lies ahead for the stock?
5 Earnings Charts to Kick off Earnings Season
by Tracey Ryniec
Investors should be watching more than just the big banks this week.
Cintas (CTAS) to Report Q4 Earnings Results: What's in Store?
by Zacks Equity Research
Cintas (CTAS) Q4 earnings to reflect strength in healthcare and hygiene markets, and healthy supply chain and distribution network. Coronavirus woes in some markets are likely to have been concerning.
Cintas (CTAS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Cintas (CTAS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cintas (CTAS) Exhibits Solid Prospects, Challenges Persist
by Zacks Equity Research
Cintas (CTAS) is likely to benefit from strength across its healthcare and hygiene end markets, acquired asset and shareholder-friendly policies. Soft end markets and high-debt are concerning.
Cintas (CTAS) Up 2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Cintas (CTAS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Cintas (CTAS) Stock Might be a Great Pick
by Zacks Equity Research
Cintas (CTAS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Why Cintas (CTAS) Stock Might be a Great Pick
by Zacks Equity Research
Cintas (CTAS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Cintas (CTAS) Exhibits Strong Prospects Amid Challenges
by Zacks Equity Research
Cintas (CTAS) stands to gain from strength across its healthcare and hygiene end markets, acquired asset and shareholder-friendly policies. End-market challenges and high-debt are concerning.
Cintas (CTAS) Tops on Q3 Earnings, Gives Solid Sales View
by Zacks Equity Research
Cintas' (CTAS) Q3 results reflect the impacts of lower revenues as well as a decline in costs and expenses. The company anticipates Q4 revenues to improve sequentially.
Cintas (CTAS) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Cintas (CTAS) delivered earnings and revenue surprises of 7.24% and 1.15%, respectively, for the quarter ended February 2021. Do the numbers hold clues to what lies ahead for the stock?
Titan Machinery (TITN) to Report Q4 Earnings: What to Expect?
by Zacks Equity Research
Titan Machinery (TITN) fourth-quarter fiscal 2021 results are likely to reflect favorable agriculture market fundamentals, higher construction demand and efforts to control operating expenses.
MP Materials (MP) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
MP Materials' (MP) fourth-quarter results are likely to reflect higher production realized price owing to improved efficiency of its processing operations and higher average realized prices.
Will Cintas (CTAS) Keep Its Earnings Streak Alive in Q3?
by Zacks Equity Research
Cintas' (CTAS) Q3 earnings results to reflect the impacts of one less working day and the pandemic-related woes. The healthy demand in hygiene and healthcare markets is likely to have been appealing.
Should You Buy Cintas (CTAS) Ahead of Earnings?
by Zacks Equity Research
Cintas (CTAS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Energy Fuels (UUUU) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Energy Fuels' (UUUU) fourth-quarter results are likely to reflect its decision to withhold uranium and vanadium sales until prices rise. A debt free balance sheet and cost cutting efforts will aid margins.
Cintas (CTAS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Cintas (CTAS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Hot Upcoming Earnings Charts
by Tracey Ryniec
Earnings season is winding down over the next 2 weeks but there are still incredible earnings charts still to come.